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Abstract
Background: So far there have been no studies focusing on the prevalence of a wide spectrum of oral mucosal
lesions (OML) in patients with dermatologic diseases. This is noteworthy as skin lesions are strongly associated with
oral lesions and could easily be neglected by dentists. This study aimed to estimate the frequency and socio-
behavioural correlates of OML in skin diseased patients attending outpatient’s facility of Khartoum Teaching
Hospital - Dermatology Clinic, Sudan.
Methods: A cross-sectional hospital-based study was conducted in Khartoum from October 2008 to January 2009.
A total of 588 patients (mean age 37.2 ± 16 years, 50.3% females) completed an oral examination and a personal
interview of which 544 patients (mean age 37.1 ± 15.9 years, 50% females) with confirmed skin disease diagnosis
were included for further analyses. OML were recorded using the World Health Organization criteria (WHO). Biopsy
and smear were used as adjuvant techniques for confirmation. Data were analysed using the Statistical Package for
Social Science (Version 15.0.1). Cross tabulation and Chi-square with Fisher’s exact test were used.
Results: A total of 438 OML were registered in 315 (57.9%, males: 54.6% versus females: 45.6%, p < 0.05) skin
diseased patients. Thus, a certain number of patients had more than one type of OML. Tongue lesions were the
most frequently diagnosed OML (23.3%), followed in descending order by white lesions (19.1%), red and blue lesions
(11%) and vesiculobullous diseases (6%). OML in various skin diseases were; vesiculobullous reaction pattern (72.2%),
lichenoid reaction pattern (60.5%), infectious lesions (56.5%), psoriasiform reaction pattern (56.7%), and spongiotic
reaction pattern (46.8%). Presence of OML in skin diseased patients was most frequent in older age groups (62.4%
older versus 52.7% younger, p < 0.05), in males (63.2% males versus 52.6% females, p < 0.05), patients with a
systemic disease (65.2% with systemic versus 51.9% without systemic disease, p < 0.05) and among current users of
smokeless tobacco (toombak) (77% current use versus 54.8% no use, p < 0.00).
Conclusions: OML were frequently diagnosed in skin diseased patients and varied systematically with age, gender,
systemic condition and use of toombak. The high prevalence of OML emphasizes the importance of routine
examination of oral mucosa in a dermatology clinic.
Background
Epidemiological studies of oral mucosal lesions (OML)
are rare globally in comparison with studies on caries
and periodontal diseases [1]. Whilst caries and periodon-
tal diseases constitute the most prevalent oral diseases
worldwide, cancrum oris, oral manifestations of HIV/
AIDS, and oral cancer constitute the main burden of oral
diseases in deprived communities in sub Saharan Africa
[2]. As the pattern of oral diseases vary across countries,
site specific epidemiological studies are needed to address
the most commonly occurring oral diseases in order to
plan for oral health care service [1,3]
To estimate the prevalence, incidence, distribution and
causal factors of OML, studies from the general popula-
tion are needed. However, population based studies are
difficult to carry out because they are expensive and time
consuming. The most extensive surveys on OML have
been reported from Sweden, America, Malaysia and India
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selected population groups; hospital attendees, the elderly,
school children and patients with specific diseases, such as
hepatitis C, diabetes, renal and skin diseases [8-16].
Absence of use of standardized methodological design in
epidemiological studies of OML has shown substantial dis-
parity in the prevalence of these lesions across different
settings worldwide. In general, previous studies have
shown that OML tend to increase with age and being a
male, and also with lifestyle patterns such as tobacco and
alcohol consumption [6,12,17].
In oral medicine, dermatologic diseases have got special
attention as OML may be the primary clinical feature or
the only sign of various mucocutaneous diseases [18-20].
Focusing on patients referred to a dermatologic clinic,
Ramirez-Amador et al [21] reported a prevalence of 35%
OML in subjects affected with mucocutaneous conditions.
Pemphigus vulgaris, lichen planus, candidiasis, and recur-
rent aphthous ulcers were the most frequently diagnosed
conditions [21]. Yet, there has been no studies focusing on
the prevalence of a wide spectrum of different types of
OML in patients with dermatologic diseases. This is note-
worthy as a certain amount of skin lesions are strongly
associated with oral lesions and could be neglected by
dentists due to lack of information and/or improper diag-
nosis [22]. Dentists are often the first to be consulted by
patients who develop acute oro-facial pain. Therefore,
improving the knowledge about the frequency and diver-
sity of OML at the dermatology clinic will strengthen and
enhance interdisciplinary and multispectral approaches as
opposed to a single sector approach in the management of
such patients. Moreover, OML in skin diseases deserve
special attention, considering that some are life-threaten-
ing, while others have great impact on individuals and
society in terms of pain, discomfort and social and func-
tional limitations [1]. In the Sudan, studies on OML have
focused on toombak (Sudanese smokeless tobacco)-asso-
ciated lesions since several clinical and epidemiological
studies have identified toombak use as a possible risk fac-
tor for oral cancer [23,24].
Purpose
The purpose of this study was to estimate the frequency,
diversity and socio-behavioural correlates of different
types of OML in adult patients with dermatological dis-
eases attending outpatient’s facility of Khartoum Teaching
Hospital (KTH) - Dermatology Clinic, Sudan.
Methods
Sampling procedure
A cross sectional hospital-based study was carried out
focusing on patients aged 18 years and above with skin
lesions, attending an outpatient dermatologic clinic at
KTH from October 2008 to January 2009. KTH is the
largest national hospital in Sudan. It is an open public and
referral hospital receiving patients from all states of the
country. A minimum sample size of 500 patients was cal-
culated based on an assumed prevalence of OML in skin
diseased patients of 5%, a confidence interval of 95%, and
an absolute precision of 0.02. All patients (n = 4235)
attending the outpatient facility during the survey period
were invited to participate in the study. The patients were
informed in detail about the study procedure and that
they could decline at any time without negative conse-
quences, after having given consent.
A total of 1540 subjects (36.4%) accepted verbally to par-
ticipate in the study. Fear of taking biopsy for asympto-
matic lesions and time consuming examinations (oral
examination, interview, and biopsy when needed) were the
main reasons for not volunteering to participate. Some
refusals did not give reason for non-participation. Among
those who initially accepted to participate, 544 (544/1540,
35.3%) patients were included in the study. Reasons for
none consenting were patients’ disappearance and limited
resources. Confidentiality of the patients was maintained.
The participants were informed about their oral condi-
tions, and health education was provided. Those who
needed dental services were referred to the University of
Science and Technology (UST), Faculty of Dentistry, for
further investigation and management. Participation was
voluntary. Written informed consent or finger print for
participation and publication of the study was obtained
from patients or their parents/guardians. The research
conformed to the Helsinki Declaration and ethical clear-
ance, and approval letters were obtained by the participat-
ing institutions’ committees (UST and KTH, Department
of Dermatology, in Sudan). In Norway, the ethical
approval was obtained from the Regional Committee for
Medical Ethics in Research.
Interview
A face-to-face interview was conducted by two trained
dentists. The structured interview schedule contained
questions regarding socio-demographics (gender, age,
education, occupation and place of residence during the
last 5 years), health and oral health related characteristics
and lifestyle (smoking, use of toombak or alcohol). The
interview schedule was constructed in English and then
translated and used in Arabic. Forward and backward
translations were done by two independent Sudanese
professional translators in Arabic and English language.
Oral health related behaviours were assessed in terms of
use of toombak, alcohol and smoking. Use of alcohol and
use of toombak was assessed using a 5-point scale: (1)
Every day; (2) Several times a week; (3) Sometimes; (4)
Never; (5) Former use. Two dummy variables were con-
structed yielding the categories 0 = never (including the
original categories 4), 1 = yes (including the original
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using a 4-points scale: (1) Every day; (2) Sometimes; (3)
Former use; (4) Never. Those scales were dichotomized
into 1 = smoke (including the original categories1, 2 and
3), 0 = never smoke (including the original categories 4).
Skin examination
An expert dermatologist (HS) evaluated the patient’s der-
matological disease through information obtained in a
structured interview conducted in the outpatient depart-
ment of the dermatology clinic. Elements evaluated during
skin examination were chief complains, and duration and
history of chief complains. Past history and family history
were also recorded.
Clinical oral examination
Systematic comprehensive extra-oral and intra-oral clini-
cal examinations based on visual inspection and palpa-
tion, following the World Health Organization (WHO)
criteria for field surveys [25] were carried out by a dentist
(NMS) who received a standard training in diagnosis of
OML before the data collection (The Gade Institute,
Section for Pathology, and Department of Clinical
Dentistry-Section for Oral Surgery and Oral Medicine,
University of Bergen, Norway). Oral examination was
performed with the subject lying on a medical couch in
the outpatient’s section of the Department of Dermatol-
ogy, KTH. All instruments used for oral examination and
biopsy were obtained from UST. A head light and an arti-
ficial light, mouth mirrors, spatulas, and sterile gauze
were used. Occasionally, a cotton swab was used to
remove debris to test whether a white lesion could be
wiped off. Dentures were removed prior to examination.
In those cases requiring further examination; diascopy,
smears for Candida albicans, punch and incision biopsies
were performed to establish precise accurate diagnosis. In
addition, selected sections were stained for examination
of Candida albicans or melanin. Final diagnoses of all
lesions were confirmed by an expert oral pathologist
(ACJ). Skin lesions and OML encountered during the
survey were photographed using a digital camera (Canon
EOS 400D).
Clinical parameters were recorded using a structured
questionnaire modified from the WHO OML form
assessment [25,26]. Parameters which were recorded
were; chief complains, disease history, clinical features of
the lesion, anatomical location, size, colour, past history,
medications used, and associated etiological factors. Self-
reported condition of the oral mucosa was also ascer-
tained by asking the patients about dryness of mouth,
ulceration, pain, difficulties in swallowing, and burning
sensation. The clinical diagnoses of OML were sorted
into 14 disease groups, and the total number of types of
lesions within each disease group was assessed. In
addition, the total number of patients who were diag-
nosed with any lesion in each separate disease group was
counted. Individual patient could have more than one
type of OML diagnosed. Consequently, the number of
OML would exceed the number of patients.
Diagnostic criteria for oral mucosal lesions
An OML was defined as any abnormal change or any
swelling on the oral mucosal surface. Diagnostic criteria
for OML were based on Axell criteria and those defined in
previous studies and reviews [5,25,27,28]. Thus, median
rhomboid glossitis was defined as asymptomatic, smooth
to lobulated well demarcated erythematous zone, sur-
rounded by a sharp furrow that affects midline of posterior
dorsal tongue. Atrophy of tongue papillae not compatible
with the criteria set for median rhomboid glossitis, has
been registered as atrophy of tongue papillae. Vitiligo was
defined as depigmented macules and patches that have
relatively distinct and possibly hyperpigmented margins
present in the lips. The lesion should associate with diag-
nosed vitiligo elsewhere in the skin. Lichenoid lesions
were defined as lesions that have in common basal cell
damage, have a lichen planus like aspect, but that lack one
or more characteristic clinical aspects [29]. Erythema was
defined as redness of the mucosa, caused by hyperemia of
the mucosal capillaries. The lesion should disappear on
finger pressure (blanching).
In addition to strictly intraoral lesions, angular cheilitis
and perioral dermatitis were also recorded. Linea alba,
cheek biting, leukoedema, lingual varicose, Fordyce’sg r a n -
ules, and excessive melanin racial pigmentation were
excluded from the study.
Statistical analysis
Data were analyzed using the Statistical Packages for
Social Sciences (SPSS, version 15.0). The level of statistical
significance was set at 5%. Cross tabulation and Chi-
square with Fisher’s exact test were used to test the statis-
tical significance of the relationships between skin disease
groups and types OML on the one hand side and socio-
behavioural variables on the other.
Results
Sample profile
A total of 544 patients with a skin disease diagnosis parti-
cipated in the present study. The mean age was 37.1 ±
15.9 years (range 18-85), 50% were females and 77% were
permanent residents of Khartoum during the previous 5
years. Males were more frequently employed than females
(72.6% versus 27.4%, p < 0.001), whereas use of smoking,
toombak or alcohol was more reported in males than
females (p < 0.05). Totals of 17.7%, 12.7% and 4.3% con-
firmed former or current smoking, use of toombak and
alcohol use, respectively (Table 1).
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Ninety-four different types of skin lesions, grouped into
22 categories of skin diseases, were diagnosed. The cate-
gories of skin diseases that affected less than 10 patients
(13 of the 22 categories) were grouped together and
labelled “others”. Spongiotic reaction pattern was the
most frequently diagnosed dermatological disease group
(126/544, 23.2%), followed in descending order by skin
infectious diseases (115/544, 21.1%, i.e. fungal infections
9.6%, viral infection 6.8%, bacterial infection 2.9%, and
protozoal infection 1.8%), vesiculobullous reaction
pattern (54/544, 9.9%), and disorders of cutaneous appen-
dages (48/544, 8.8%). The least frequently diagnosed
group was tumours (12/544, 2.2%) (Figure 1). Disorder of
pigmentation was more common in females than in
males (78% versus 22%, p < 0.001). Vesiculobullous reac-
tion pattern and disorders of cutaneous appendages were
most common in older (32.7% versus 67.3%) and younger
(85.4% versus 14.6%) patients, respectively (p < 0.05).
Oral mucosal lesions profile
In total, 315 of the 544 patients included in the study
had at least one clinically recognized type of OML
(57.9%). A certain amount of the patients had more
than one type of OML, thus the total number of OML
recorded in the 315 patients was 438. Of those affected,
202 (64.1%) had one type of OML, 78 (24.8%) had two
types of OML, and 35 (11.1%) had three or more types
of OML. A total of 51 different clinical diagnoses were
recorded. For each patient, one type of OML was only
recorded once, although in some patients the OML
could be manifested at several locations. Only 15.9%
(n = 50) of the patients agreed to undergo punch biopsy
confirmation. Absence of epithelial dysplasia was con-
firmed in all biopsies taken from lesions such as oral
leukoplakia, frictional lesion, and snuff dipper’sl e s i o n s .
The age of patients affected by OML ranged from 18 to
81 years, with an average of 38.6 years (±16.5).
As shown in Table 2, tongue lesions were the most fre-
quently diagnosed OML (23.3%) followed in descending
order by white lesions (19.1%), red and blue lesions (11%)
and vesiculobullous diseases (6%). The least frequently
d i a g n o s e dO M Lg r o u pw a smalignant tumours (0.2%).
White lesions (42.2% versus 57.8%) and the red and blue
lesions (37.3% versus 62.7%) occurred most frequently in
older patients (p < 0.05). Ulcerative conditions were most
frequently diagnosed in males (18% versus 6%, p < 0.05).
Coated tongue (48.0%) and tongue tie (3.1%) were the
most frequently occurring OML within tongue lesions,
whereas snuff dipper lesions/toombak-associated lesions
Table 1 Socio-demographic and behavioural distribution of patients with skin disease by sex (n = 544)
Variables Female n (%) Male n (%) Total n (%)
Age
Younger (18-32 yrs) 144 (51.6) 135 (48.4) 279 (52.2)
Older (33-85 yrs) 123 (48.2) 132 (51.8) 255 (47.8)
Occupation
Employed 89 (27.4) 236 (72.6)* 325 (59.9)
Unemployed 183 (83.9) 35 (16.1) 218 (40.1)
Education
Lower education (illiterate/primary school) 143 (53.6) 124 (46.4) 267 (49.9)
Higher education 126 (47) 142 (53) 268 (50.1)
Residence
Residence last 5 yr: Khartoum 207 (49.9) 208 (50.1) 415 (77)
Residence last 5 yr: outside 65 (52.4) 59 (47.6) 124 (23)
Medical history
No systemic condition 138 (46.5) 159 (53.5) 297 (54.6)
Presence of systemic condition 134 (54.3) 113 (45.7) 247 (45.4)
Smoking
Never 263 (59.5) 179 (40.5) 442 (82.3)
Former/current use 6 (6.3) 89 (93.7)** 95 (17.7)
Toombak use
Never 263 (56.3) 204 (43.7) 467 (87.3)
Former/current use 8 (11.8) 60 (88.2)** 68 (12.7)
Alcohol use
Never 269 (52.5) 243 (47.5) 512 (95.7)
Former/current use 2 (8.7) 21 (91.3)** 23 (4.3)
￿ * p < 0.05 ** p < 0.001.
￿ The total number in the different categories did not add to 544 owing to missing values.
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(46.9%) were the most frequently occurring diagnoses in
white lesions, red and blue lesions and vesiculobullous
diseases, respectively. A total of 0.2% of the patients
investigated presented with Kaposi’s sarcoma, the only
lesion in the group of malignant tumours.
Table 3 depicts the frequency distribution of OML
groups within each skin disease group investigated. OML
o c c u r r e dm o s tf r e q u e n t l yi nt h eg r o u po fskin vesiculo-
bullous reaction pattern (72.2%), followed in descending
order by tumours (66.7%), and lichenoid reaction pattern
(60.5%). OML occurred least frequently in the skin dis-
ease group of spongiotic reaction pattern (46.8%). Tongue
lesions were the most frequently occurring OML group
across the various skin diseases. The highest prevalence
(33.3%) of the tongue lesions was found among psoriasi-
form reaction pattern. On the other hand, white lesions
occurred most frequently in the skin disease groups of
disorders of pigmentation and lichenoid reaction pattern
amounting to 43.9% and 34.2%, respectively.
As shown in Table 4, OML occurred more frequently in
older than younger patients (62.4% versus 52.7%, p <
0.05), in males than in females (63.2% versus 52.6%, p <
0.05) and more frequently in patients with than without a
medical diagnosis (65% versus 51.9%, p < 0.05). Moreover,
OML occurred more frequently in toombak users than in
their counterparts who had never used toombak (77.9%
versus 54.8%, p < 0.00).
Discussion
Frequency and diversity of oral mucosal lesions
To our knowledge this study is the first to assess the fre-
quency and diversity of OML in dermatologic patients, a
selected group of the Sudanese adult population. The
study group comprised patients with a wide range of der-
matological diseases, yielding small numbers in each
group, thus limiting the probability for stratified analyses.
The most frequently occurring groups of dermatological
diseases were spongiotic reaction pattern, infectious dis-
eases,a n dvesiculobullous diseases. This accords with the
results of a recent survey by the International Foundation
of Dermatology, reporting that infectious disease, derma-
titis, and HIV-related skin disease are the main skin der-
matological conditions at the community level worldwide
[30].
According to the present results, about 58% of the sub-
jects investigated suffered from at least one type of OML,
and the occurrence of any OML varied across groups of
dermatological diseases from 46.8% in spongiotic to
72.2% in vesiculobullous reaction patterns. Tongue lesions
were the most frequently occurring OML group (23.3%)
followed by white lesions (19%), red and blue lesions
(11%) and vesiculobullous diseases (6%). White lesions
and red and blue lesions varied systematically with age,
being most frequent in older persons, whereas ulcerative
conditions were most common in males. Coated tongue,
snuff dippers lesion, erythema and pemphigus vulgaris
Figure 1 Frequencies of skin disease categories.
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diseased patients with OML and within the 14 most frequently occurring OML groups
Oral mucosal lesions Proportion with a specific
lesion in the total group of
patients
(n = 544)
Proportion with a specific lesion
in the total group of patients
with any OML
(n = 315)
Proportion with specific
lesion within 14 OML
groups
Biopsy
Tongue lesions n (%) % %
Coated tongue 61 (11.2) 19.4 48.0
Fissured tongue 26 (4.8) 8.3 20.5
Geographic tongue 23 (4.2) 7.3 18.1 2(+ve)*
Atrophy of tongue papillae 17 (3.1) 5.4 13.4 1(+ve)
Geographic tongue+Fissured
tongue
12 (2.2) 3.8 9.4
Tongue-tie 4 (0.7) 1.3 3.1
Total number of patients with
any tongue lesion ¶
127 (23.3) 40.3
White lesions
Snuff dipper’s lesion 30 (5.5) 9.5 28.8 8(+ve)
Frictional lesions 25 (4.6) 7.9 24.0 4(+ve)
Leukoplakia 17 (3.1) 5.4 16.3 5(+ve)
Vitiligo 16 (2.9) 5.1 15.4
Nicotine stomatitis 7 (1.3) 2.2 6.7
Lichen planus 5 (0.9) 1.6 4.8 3(+ve)
Lupus erythematosus 4 (0.7) 1.3 3.8 1(-ve)§
Unspecified nicotine stomatitis 3 (0.6) 1.0 2.9
Lichenoid lesions 1 (0.2) 0.3 1.0 1(+ve)
Total number of patients with
any white lesion ¶
104 (19.1) 33.0
Red and blue lesions
Erythema 29 (5.3) 9.2 48.3 2(-ve)
Petechia 25 (4.6) 7.9 41.7
Erosion 7 (1.3) 2.2 11.7
Hemangioma 3 (0.6) 1.0 5.0
Total number of patients with
any red and blue lesion ¶
60 (11) 19.0 100
Vesiculobullous diseases
Pemphigus vulgaris 15(2.8) 4.8 46.9 9(8+ve)
Chickenpox 8(1.5) 2.5 25
Bullous pemphigoid 6(1.1) 1.9 18.7 3(-ve)
Herpes labialis 2(0.4) 0.6 6.2
Vesiculobullous lesion (not
verified)
1(0.2) 0.3 3.1
Total number of patients with
any vesiculobullous disease
32 (6) 10.2 100
Ulcerative conditions
RAS 16 (2.9) 5.1 66.7 1(+ve)
Drug reaction 3 (0.6) 1.0 12.5
Stevens-Johonson syndrome 2 (0.4) 0.6 8.3
Erythema multiforme 1 (0.2) 0.3 4.2
Traumatic ulcer 1 (0.2) 0.3 4.2
Unspecified ulcer 1 (0.2) 0.3 4.2
Total number of patients with
any ulcerative condition
24 (4.5) 7.6 100
Pigmented Lesions
Melanotic macules 20 (3.7) 6.3 95 1(+ve)
Gingival tattoo 1 (0.2) 0.3 4.8
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diseased patients with OML and within the 14 most frequently occurring OML groups (Continued)
Total number of patients with
any pigmented Lesion
21 (3.9) 6.7 100
Connective tissue lesions
Fibroepithelial polyp 9 (1.7) 2.9 81.8 4(+ve)
Denture induced fibrous
hyperplasia
2 (0.4) 0.6 18.2
Total number of patients with
any connective tissue lesion
11 (2.1) 3.5 100
Fungal infections
Acute erythematous candidiasis 3 (0.6) 1.0 30 1(-ve)
Median rhomboid glossitis 3 (0.6) 1.0 30
Pseodomembranous candidiasis 3 (0.6) 1.0 30
Angular cheilitis 2 (0.4) 0.6 20
Chronic hyperplastic candidiasis 1 (0.2) 0.3 10
Total number of patients with
any fungal infection ¶
10 (1.8) 3.2 100
Benign nonodontogenic tumors
Soft tumor like lesion 4 (0.7) 1.3 66.7 1(-ve)
Exostosis 1 (0.2) 0.3 16.7
Palatal tori 1 (0.2) 0.3 16.7
Total number of patients with
any benign nonodontogenic
tumor
6 (11) 1.9 100
Perioral lesions
Perioral dermatitis 4 (0.7) 1.3 80
Perioral wart 1 (0.2) 0.3 20
Total number of patients with
any perioral lesion
5 (0.9) 1.6 100
Lip lesions
Unspecified cheilitis 2 (0.4) 0.6 40
Hypopigmented lips 2 (0.4) 0.6 40
Cheilitis glandularis 1 (0.2) 0.3 20
Total number of patients with
any lip lesion
5 (1.0) 1.6 100
Verrucal papillary lesions
Papillary hyperplasia 3 (0.6) 1.0 75 1(+ve)
Focal epithelial hyperplasia 1 (0.2) 0.3 25
Total number of patients with
any verrucal papillary lesion
4 (0.7) 1.3 100
Salivary gland diseases
Mucocele 2 (0.4) 0.6 100 2(+ve)
Total number of patients with
any salivary gland disease
2
Malignant tumours
Kaposi sarcoma 1 (0.2) 0.3 100
Total number of patients with
any malignant tumour
1
If we exclude the diagnosis of (fissured tongue + geographic tongue) as one disease entity;
￿ Total no. of fissured tongue will be 38 (7% of study population)
￿ Total no. of geographic tongue will be 35 (6.4% of study population)
* (+ve) = Confirmed diagnosis
§ (-ve) = Not confirmed, final diagnosis based on history and clinical picture.
¶ The sum of the categories listed may not equal the total number due to the present of more than one lesion in one patient.
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Skin diseases (groups) Patients with any OML
(n = 315)
Tongue
(n = 127)
White
(n = 104)
Red
(n = 60)
Vesiculobullous
(n = 32)
Ulcerative
(n = 24)
Pigmented
(n = 21)
Connective
(n = 11)
Fungal
(n = 10)
Others
(n = 23)
Spongiotic 59 27 22 16 - 3 6 - 1 5
(n = 126) (46.8) (21.4) (17.5) (12.7) (02.4) (04.8) (00.8) (04.0)
Infectious lesions 65 25 18 12 9 2 3 - 1 7
(n = 115) (56.5) (21.7) (15.7) (10.4) (07.8) (01.7) (02.6) (00.9) (06.1)
Vesiculobullous 39 11 3 - 22 5 3 1 4 2
(n = 54) (72.2) (20.4) (05.6) (40.7) (09.3) (05.6) (01.9) (07.4) (03.7)
Cutaneous 26 9 9 3 - 3 1 3 - 1
(n = 48) (54.2) (18.8) (18.8) (06.3) (06.3) (02.1) (06.3) (02.1)
Pigmentation 24 7 18 7 - - 1 2 - -
(n = 41) (58.5) (17.1) (43.9) (17.1) (02.4) (04.9)
Lichenoid 23 11 13 5 - 2 1 1 1
(n = 38) (60.5) (28.9) (34.2) (13.2) (05.3) (02.6) (02.6) (02.6)
Psoriasiform 17 10 7 5 - - 1 1 1 1
(n = 30) (56.7) (33.3) (23.3) (16.7) (03.3) (03.3) (03.3) (03.3)
Vasculopathic 13 8 2 3 - 3 1 - 1 -
(n = 25) (52.0) (32.0) (08.0) (12.0) (12.0) (04.0) (04.0)
Tumour 83 1 - - 1 1 - 2
(n = 12) (66.7) (25.0) (08.3) (08.3) (08.3) (16.7)
Others 41 16 11 9 1 5 4 2 1 5
(n = 55) (74.5) (29.1) (20.0) (16.4) (01.8) (09.1) (07.3) (03.6) (01.8) (09.1)
￿ OML (others); non odontogenic tumors, perioral lesions, lip lesions, verrucal papillary lesions, mucocele, oral malignancy
￿ Some patients were recorded more than one time because they appeared under more than one disease group
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3were the OML most frequently observed in the groups of
tongue lesions, white lesions, red and blue lesions and
vesiculobullous diseases, respectively.
Study Limitations
The present findings should be interpreted with caution
due to some limitations. Patients’ refusal to volunteer for
biopsy might have led to some misclassifications. Thus,
some lesions that needed histological confirmation
(leukoplakia, lupus erythematosus, pemphigus vulgaris,
fibroepithelial polyp, chronic hyperplastic candidiasis,
cheilitis glandularis, focal epithelial hyperplasia, Kaposi’s
sarcoma and some others) were diagnosed clinically and
might contain error. Absence of standard methodological
approaches and lack of agreed-upon diagnostic criteria,
make comparison of epidemiological studies concerning
the prevalence of OML difficult. In spite of the limita-
tions associated with diagnostic criteria, all mucosal
pathological alterations were identified in the present
study.
Being a hospital based study; it is not possible to gen-
eralize from the study group to any larger population of
skin diseased individuals inside or outside Khartoum.
This is due to the rich geographical and socio-cultural
diversity within Sudan, as well as the low utilization rate
of health facilities generally observed in any developing
country [31,32]. Although the KTH received patients
that have been referred from all over the country, biases
in the study group might have been introduced due to
differing referral procedures as well as the moderate
response rate.
It is unsure how close an approximation the present
figures are to the prevalence of OML in the general adult
population of Sudan. Probably, the rates of OML pre-
sented in this study might be overestimated both with
respect to the Sudanese population in general as well as to
the population of adults suffering dermatological pro-
blems. Self-selection bias was considered to influence the
result of the study as patients were more likely to respond
when they had OML (the characteristic of interest).
Table 4 Skin diseases with oral lesions and with at least two OML by socio-demographic and behavioural factors (n = 544)
Skin disease with OML Skin disease with ≥ 2 oral lesions
N = 315 N = 113
Age n (%) n (%)
Younger (18-32 yrs) 147 (52.7) 42 (28.6)
Older (33-85 yrs) 159 (62.4)* 69 (43.4)
Sex
Females 143 (52.6) 43 (30.1)
Males 172 (63.2)* 70 (40.7)
Employment status
Employed 197 (60.6) 69 (35)
Non employed 117 (53.7) 44 (37.6)
Education
Lower education (illiterate/primary school) 162 (60.7) 65 (40.1)
Higher education 146 (54.5) 47 (32.2)
Residence
Khartoum 235 (56.6) 88 (37.4)
Outside Khartoum 77 (62.1) 24 (31.2)
Medical diagnosis
No systemic condition 154 (51.9) 53 (34.4)
Presence of systemic condition 161 (65.2)* 60 (37.3)
Toombak use
Never 256 (54.8) 90 (35.2)
Former/current use 53 (77.9)** 22 (41.5)
Smoking
Never 251 (56.8) 89 (35.5)
Former/current use 60 (63.2) 23 (38.3)
Alcohol
Never 293 (57.2) 103 (35.2)
Former/current use 16 (69.6) 9 (56.3)
￿ * p < 0.05 ** p < 0.00.
￿ The sum of the categories listed may not equal the total number due to lack of information.
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OML, the present figures might be biased towards those
for which people are more inclined to seek treatment,
whereas other conditions are less likely to be identified in
hospital based prevalence studies. Community based sur-
veys based on random samples from the broader adult
population should be recommended for future studies to
estimate the actual prevalence and the health burden of
OML in this country.
Since the precision of estimates tend to decrease with
decreasing prevalence, the prevalence rates of rare condi-
tions (≤ 1%) should be interpreted with particular caution.
In addition, populations with different distributions of the
risk factors identified for OML are not directly comparable
without adjustment. Noteworthy the absence of an official
patient’s medical journal has created uncertainty regarding
participants’ self-reported medical condition and lifestyle
patterns. A major limitation of self-reported data is recall
biases in terms of underreporting of socially undesired
events and a tendency to recall events as having occurred
more recently than they actually did [33]. Sensitive events,
tobacco and alcohol use and some medical diagnoses
would probably be under reported due to social stigma
and social desirability.
Comparison of present findings with those of previous
studies
In spite of its limitations, the present study provides
important information about the frequency and diversity
of OML in patients with various dermatological diseases
as well as the social and behavioural factors that discrimi-
nate between skin diseased patients with and without
OML. Moreover, OML in the present study may appear as
a part of mucocutaneous diseases, a manifestation of
systemic diseases (metabolic or immunological), or an
expression of drug reaction. Some OML diagnosed could
be attributed to trauma, infection, or denture use, or they
could be a manifestation of specific cultural habits, like
use of toombak. Due to the cross sectional nature of the
present study, any causal relationship could, however, not
be concluded upon.
Compared with the frequency of patients with OML
observed in this study (57.9%), previous ones have shown
point prevalence in the range 25% - 61.6% [6,9,34-36].
Specifically, the frequency of patients with OML in the
present study group was higher than those observed in
the Cambodian (4.9%) [37] Malaysian (9.7%) [7], Spanish
( 5 1 % )[ 1 2 ]a n dT u r k i s h( 4 2 % )populations [36]. It was
lower than that observed in population in Ljubljana
(61.6%), but almost similar to the prevalence estimated in
Spanish dental patients (58.7%) [8,35]. In accordance
with the NHANES III [6] and the Swedish study pub-
l i s h e db yA x e l l[ 5 ] ,t h ep r e s e n ts t u d yu s e dt h eW H O
diagnostic criteria and Axell’s diagnostic criteria [5,25].
Thus, the present results are to some extent comparable
with those previous studies, in spite that NHANES III
and the study by Axell used large probability samples
from the general populations. The frequency observed in
this study was higher than that reported in NHANES III,
amounting 28% in US adults aged 17 years and above.
Consistent with the results of NHANES III and other
studies, the frequency of patients with OML presented in
this study varied systematically and positively with being
am a l ea n dw i t hi n c r e a s i n ga g e. Other epidemiological
studies have shown an opposite sex gradient or no
systematic variation according to sex [9,38,39]. Sex differ-
ences in the occurrence of OML might be attributed to
the high consumption of toombak by males, differences
in genetic factors, social responsibility and masculinity
believes [40]. Use of toombak was reported by 12.5% of
t h et o t a ls t u d yg r o u p .I nas t u d ye m a n a t i n gf r o mn o r t h -
ern Sudan, the frequency of toombak use was estimated
to 40% (43, 44). Males adopt a more active outdoor life-
style and are exposed to some environmental risk factors
to a higher extent than women. In contrast, women are
more health conscious and faster to detect abnormality
in earlier stages. Older people have higher risk to develop
chronic diseases in general because of increased risk with
increasing age due to metabolic changes, medications,
prosthetic use, and psychological problem. Moreover,
economic constraints and physical status of older people
may limit their access to health care services [41,42].
Epidemiological studies have revealed that tongue
lesions constitute a considerable proportion of OML,
with prevalence rates varying across different parts of the
world. Number and type of tongue lesions involved in dif-
ferent studies have been an important factor in this varia-
bility. The present figure amounting to 23%, is lower than
that reported in some previous studies [43,44], but higher
than the rates assessed in NHANES III and in the Hun-
garian population [6,45]. Of interest was that 17 out of
30 patients (56.7%) with psoriasiform reaction pattern
had OML and that tongue lesions (33.3%) were the most
frequently occurring OML in this particular dermatologi-
cal disease group (Table 3). A study of Brazilian psoriatic
patients revealed that 59% presented with tongue lesions,
which was the most dominant OML [46]. Similar find-
ings have been reported by Hernandez-Perez et al [19].
With respect to fissured tongue, the total of 7% of
patients with fissured tongue observed in this study cor-
roborates the range reported previously [5,45,47,48].
Some few studies have reported high frequency of fis-
sured tongue [35,39,43]. Over the past few years an asso-
ciation between geographic tongue, fissured tongue and
psoriasis has been postulated. Some authors believe that
it is a natural developmental anomaly and a coincidence
finding [46,49] while others suggest a pathogenic relation
between them [50].
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Page 10 of 13Snuff dipper’s lesion was observed in 5.5% of the study
group (Table 2). This frequency is higher than that
reported in the American and Kenyan population (1.2%
and 0.4%, respectively) [6,51], but lower than that observed
in the Swedish population (15.9%) [52]. Toombak has
been known to play a major role in the aetiology of oral
cancer in the Sudan [23]. It contains at least 100-fold
higher concentrations of the carcinogenic factor tobacco
specific N-nitrosamines compared with American and
Swedish commercial snuff brands [53]. A recent study
showed that toombak induces DNA damage and cell
death in normal human oral cells more than the Swedish
snuff [54].
The frequency of oral leukoplakia (3.1%) disclosed in
this study is comparable to findings from Sweden (3.6%),
but higher than that reported in NHANES III (0.38%) [6].
Leukoplakia is a premalignant lesion with transformation
rates varying from 15.6% to 39.2% [55]. It is highly asso-
ciated with cigarette smoking [8,27,56]. Although we have
not done any further analysis of smoking as a possible risk
factor of leukoplakia, the low frequency rate of cigarette
smoking concomitant with a relatively high frequency of
oral leukoplakia as observed in this study deserves further
investigation. The high frequency of leukoplakia should be
taken seriously as leukoplakia in non-smokers is more
likely to undergo malignant transformation than leukopla-
kia in smokers [55].
A total of 4 patients (0.7%) with oral manifestation of
discoid lupus erythematosus (DLE) on vermilion border
were diagnosed in this study (Table 2). This condition has
rarely been registered in OML investigation studies. Axel
[5] reported 0.01% in a Swedish population, while Ramirez
et al [21] reported 5% in lupus patients referred to a der-
matology clinic because of oral complaints. The difference
between the present figure and that reported by Ramirez
et al may be attributed to the fact that although both data
were collected in dermatology clinic, the selection of
patients was different. The precancerous potential of oral
DLE is a controversial topic. Lu and Le [57] reported an
incidence of 13.6% epithelial dysplasia in DLE. Another
report from Scully et al [58] postulated that DLE on the
lip showed a premalignant potential. Sun exposure plays a
crucial role in the induction or exacerbation of the lupus
erythematosus and actinic cheilitis [28,59,60]. In connec-
tion to that, Wakisa et al [61] reported oral cell carcinoma
on lips of black patients with oral DLE. Noteworthy the
tropical climate in Sudan and the summer temperature
which often exceed 43°C has to be considered in interpret-
ing such lesions.
Frequency of recurrent aphthous stomatitis (RAS) has
been recorded as life time prevalence, point prevalence
and as combination of both. The present study revealed
a point prevalence of 2.9%, which is higher than 2% and
0.8% reported by Axell [5] and NHANES III [6]
respectively. Yet, it was lower than 60% and 55% in US
female student nurses and professional school students
respectively [62]. This illustrates how RAS varies accord-
ing to the study group examined. A number of factors
have been attributed to the occurrence of this pathology,
including immune dysfunction [28].
Conclusions
In conclusion, taking into consideration the selected
study group and the cross-sectional design of the study,
the results presented here cannot be generalized to a
broader population or discussed in terms of causal rela-
tionship. The results revealed that OML were frequently
diagnosed in skin diseased patients attending KTH and
varied systematically with age, gender, systemic condition
and use of toombak. Thus, this study provides informa-
tion regarding the frequency, diversity and socio-beha-
vioural correlates of OML of an important sub group of
the Sudanese population that has never been disclosed
before. Of particular significance are those lesions having
a potential of malignant transformation. Accordingly, fre-
quent and regular inspection of the oral cavity of the skin
diseased patients must be emphasized. Consequently, an
interdisciplinary approach in the management of such
patients is highly recommended.
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